Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: Evidence for translational regulation and against Fas ligand retention in secretory lysosomes

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 5095-5102

  Xiao, Sheng ^a   Deshmukh, Umesh S ^a   Jodo, Satoshi ^b   Koike, Takao ^b   Sharma, Rahul ^a   Furusaki, Akiro ^b   Sung, Sun Sang J ^a   Ju, Shyr Te ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; PROLINE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STRAIN COS7; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; DOWN REGULATION; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT;

EID: 6344236871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.5095     Document Type: Article

References (49)

1. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
2. Trauth, B. C., C. Klas, M. J. Peters, S. Matzku, P. W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
3. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356:314.
4. Locksley, R., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487.
5. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
6. Lynch, D. H., M. L. Watson, M. L. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand is mutated in the gld mice and is part of a TNF family gene cluster. Immunity 1:131.
7. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
8. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
9. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
10. Ozdemirli, M., M. el-Khatib, L. C. Foote, J. K. M. Wang, A. Marshak-Rothstein, T. L. Rothstein, and S.-T. Ju. 1996. Fas (CD95)/FasL interactions regulate antigen-specific, MHC-restricted T/B cell proliferative responses. Eur. J. Immunol. 26:415.
11. Wu, J., T. Xhou, J. He, and J. D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461.
12. Chu, J. L., J. Drappa, A. Parnassa, and K. B. Elkon. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, Etn. J. Exp. Med. 178:723.
13. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an Intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
14. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373:444.
15. Pinkoski, M. J., N. M. Droin, T. Lin, L. Genestier, T. A. Ferguson, and D. R. Green. 2002. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion. Proc. Natl. Acad. Sci. USA 99:16174.
16. Allison, J., H. M. Georgiou, A. Strasser, and D. L. Vaux. 1997. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94:3943.
17. Arai, H., D. Gordon, E. G. Nabel, and G. J. Nabel. 1997. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA 94:13862.
18. Hohlbaum, A., M. S. Moe, and A. Marshak-Rothstein. 2000. Opposing effects of transmembrane and soluble Fas-ligand on inflammation and tumor cell survival. J. Exp. Med. 191:1209.
19. Hill, L. L., A. Oiuhtit, S. M. Loughlin, M. Kripke, H. N. Ananthaswamy, and L. N. Owen-Schaub. 1999. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285:898.
20. Wei, Y., K. Chen, G. C. Sharp, H. Yagita, and H. Braley-Mullen. 2001. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. J. Immunol. 167:6678.
21. Borgerson, K. L., J. D. Bretz, and J. R. Baker, Jr. 1999. The role of Fas-mediated apoptosis in thyroid autoimmune disease. Autoimmunity 30:251.
22. Xiao, S., S.-s. J. Sung, S. M. Fu, and S.-T. Ju. 2003. Combining Fas mutation with IL-2 deficiency prevents both colitis and lupus. J. Biol. Chem. 278:52730.
23. Hohlbaum, A. M., M. S. Gregory, S.-T. Ju, and A. Marshak-Rothstein. 2001. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 167:6217.
24. Bellgrau, D., and R. C. Duke. 1999. Apoptosis and CD95 ligand in immune privileged sites. Int. Rev. Immunol. 18:547.
25. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
26. Matsui, K., A. Fine, B. Zhu, A. Marshak-Rothstein, and S.-T. Ju. 1998. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161:3469.
27. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. K. Eliason, and G. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
28. Matsui, K., S. Xiao, A. Fine, and S.-T. Ju. 2000. Role of activator protein-1 in TCR-mediated regulation of murine fasl promoter. J. Immunol. 164:3002.
29. Xiao, S., K. Matsui, A. Fine, and S.-T. Ju. 1999. FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur. J. Immunol. 29:3456.
30. Mittelstadt, P. R., and J. D. Ashwell. 1998. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18:3744.
31. Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, and C. V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416.
32. Wu, J., C. Metz, X. Xu, R. Abe, A. W. Gibson, J. C. Edberg, J. Cooke, F. Xie, G. S. Cooper, and R. P. Kimberly. 2003. A novel polymorphic CAAT/enhancer-binding protein β element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J. Immunol. 170:132.
33. Mor, G., E. Sapi, V. M. Abrahams, T. Rutherford, J. Song, X. Y. Hao, S. Muzaffar, and F. Kohen. 2003. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 170:114.
34. Schneider, P., N. Holler, J.-L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205.
35. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Down-regulation of Fas ligand by shedding. Nat. Med. 4:31.
36. Martinez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monleon, P. Lasierra, L. Larrad, A. Pinerio, M. A. Alava, and J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163:1274.
37. Strelow, D., S. Jodo, and S.-T. Ju. 2000. Retroviral membrane display of apoptotic effector molecules. Proc. Nat. Acad. Sci. USA 97:4209.
38. Jodo, S., S. Xiao, A. Hohlbaum, D. Strehlow, A, Marshak-Rothstein, and S.-T. Ju. 2001. Apoptosis-inducing membrane vesicles: a novel agent with unique properties. J. Biol. Chem. 276:39938.
39. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
40. Bossi, G., and G. M. Griffiths. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5:90.
41. Blott, E. J., G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths. 2001. Sorting out the multiple roles of Fas ligand. J. Cell Sci. 114:2405.
42. + T cells of lpr and gld mice. Eur. J. Immunol. 31:3339.
43. Deshmukh, U. S., and C. C. Kannapell, S. M. Fu. 2002. Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins. J. Immunol. 168:5326.
44. Letourneur, F., and R. D. Klausner. 1992. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69:1143.
45. Blott, E. J., and G. M. Griffiths. 2002. Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 3:122.
46. Haddad, E. K., X. Wu, J. A. Hammer, and P. A. Henkart. 2001. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol. 152:835.
47. Gerace L., R. Gilmore, A. Johnson, P. Lazaeow, W. Neupert, E. O'Shea, and K. Weis. 2002. Intracellular compartments and protein sorting. In Molecular Biology of the Cell, 4th ed. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, eds. Garland Science, New York, p. 659.
48. Watts, A. D., N. H. Hunt, Y. Wanigasekara, G. Bloomfield, D. Wallach, B. D. Rouflgalis, and G. Chaudhri. 1999. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signaling". EMBO J. 18:2119.
49. Chijiqa, T., M. Hagiwara, and H. Kidaka. 1989. A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8- sulfonamide, and affinity purification of casein kinase I from bovine testis. J. Biol. Chem. 264:4924.